Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients.

Pathology, Research and Practice
Xingran JiangJun Lu

Abstract

Homologous recombination repair gene (HRR) mutations have been proven to be effective biomarkers for PARP inhibitor therapy for metastatic castration resistant prostate cancer. However, the frequency of HRR mutations in patients with localized and locally advanced prostate cancer is still unclear. This study investigated the profile of HRR gene mutations in Chinese localized and locally advanced prostate cancer patients. 74 patients with localized and locally advanced prostate cancer patients in Beijing Chaoyang Hospital between May 2018 and September 2019 were retrospectively included. Matched prostate cancer and histologically normal tissues were subjected to next-generation sequencing. Pathogenic alterations of 19 HRR genes were examined. Ten deleterious and suspected deleterious mutations (4 germline and 6 somatic mutations) were detected in 9 of 74 (12.16 %) patients, occurred in seven HRR-related genes, including CDK12, NBN, ATM, ATR, BRCA2, PALB2 and RAD51C. The mutation frequency of HRR genes in this study (12.16 %) was higher than TCGA cohort (7.29 %), and the mutation sites in 7 HRR genes detected in this cohort were different from those of TCGA data. Patients with HRR gene mutations had higher Gleason grade (≥ 3) (P ...Continue Reading

References

Feb 21, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Peter A Humphrey
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Jun 23, 2012·Nature·Catherine S GrassoScott A Tomlins
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Jul 20, 2016·The New England Journal of Medicine·Colin C PritchardPeter S Nelson
Sep 14, 2016·Prostate Cancer and Prostatic Diseases·R ManoO Yossepowitch
Dec 14, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Veda N GiriLeonard G Gomella
Sep 9, 2019·European Urology·MaryBeth B CulpAhmedin Jemal
Feb 25, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Rebeca LozanoElena Castro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

Heart & Lung : the Journal of Critical Care
Julie S MacMillanElizabeth S Matteson
Psychosomatic Medicine
Olga V ShcheslavskayaRichard P Sloan
Clinical Cardiology
Dmitry David GorelikVictor Froelicher
© 2021 Meta ULC. All rights reserved